The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults.

Amidst an alarming Ebola crisis, the Democratic Republic of Congo is reporting over 1,900 cases linked to the rare Bundibugyo ...

Oxford University scientists have rapidly created and launched a UK trial of Ebola jab using same technology as its ...

In 2020, a microscopic airborne pathogen stopped the world. The COVID-19 pandemic led to school closures, lockdown orders, mask mandates, and newfound hobbies for thousands of Americans. While many ...

Generating effective protection against HIV may require a complex vaccine consisting of a series of different viral proteins. Now, two trials of the potential components delivered via mRNA have ...

Pfizer Inc announced an update on their ongoing clinical study. TipRanks Welcomes a New ETF – NYSE:RANK. TipRanks has entered a new arena in the investing world, powering the in ...

The University of Maryland School of Medicine Center for Vaccine Development and Global Health (CVD), has announced the ...

A meta-analysis indicates HD-IIV is superior to SD-IIV for reducing hospitalizations in adults aged 65 years and older.

A massive, global review of mRNA vaccines has shown that they are very effective and safe. Reporting in The Lancet, ...

Receiving the recombinant shingles vaccine is associated with a lower risk of developing dementia among older adults who have ...